Browse Category

LSE:BRBY.L News 2 December 2025 - 21 January 2026

Burberry Group plc (BRBY) Stock on 2 December 2025: Analyst Hold Call, Turnaround Hopes and 2026 Forecasts

Burberry Group plc (BRBY) Stock on 2 December 2025: Analyst Hold Call, Turnaround Hopes and 2026 Forecasts

Date: 2 December 2025 – London Burberry Group plc’s stock is trading in that awkward middle ground investors love to argue about: the turnaround is clearly under way, but the numbers still carry plenty of scar tissue. As of today’s session in London, Burberry (ticker: BRBY.L) is slightly lower on the day but up strongly year‑to‑date, with fresh analyst commentary, new technical signals and another regulatory filing all landing around the stock. This piece pulls together the latest price moves, forecasts and fundamental analysis relevant as of 2 December 2025. Burberry share price on 2 December 2025 On the London

Stock Market Today

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Go toTop